我们有多接近成功分层工具,以改善性结肠炎的生物疗法?
Panu Wetwittayakhlang1,2, Gynter Kotrri2, Talat Bessissow2
1Gastroenterology and Hepatology Unit, Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand.
针对性结肠炎 (UC) 的个性化药物需要风险分层工具来预测生物治疗反应. 识别这些因素可以提高治疗效率,减少并发症,从而改善患者的治疗结果.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 药物基因组学 药物基因组学
背景情况:
- 生物疗法是性结肠炎 (UC) 的标准,但缓解率很低 (40-50%),频繁失去反应.
- 目前的UC治疗通常涉及试错方法,导致疗法无效,成本增加和治疗并发症.
研究的目的:
- 审查风险分层工具,以预测UC中的生物治疗疗效.
- 确定减少不良事件和个性化UC治疗策略的方法.
主要方法:
- 审查目前关于UC生物治疗反应预测因素的证据.
- 讨论各种风险分层工具,包括临床决策辅助工具,生物标志物,基因组学,多基因组学,内镜,成像和组织学评估.
主要成果:
- 风险分层工具对于识别可能对特定治疗有反应的患者至关重要.
- 预测因素可以帮助识别患有疾病进展和并发症高风险的患者.
结论:
- 实施风险分层对于UC生物管理中的精密医学至关重要.
- 这些工具可以选择最佳的治疗方法,提高疗效和患者安全.
更多相关视频
06:31Author Spotlight: Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids
Published on: June 2, 2023
15:49Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
Published on: October 16, 2013
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
